Table of Content


Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter’s Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition

Part 5. Global Market for L-Aspartic Acid by Application
5.1 Market Overview
5.2 Food & Beverages
5.2.1 Market Size and Forecast
5.3 Pharmaceuticals
5.3.1 Market Size and Forecast
5.4 Resin
5.4.1 Market Size and Forecast

Part 6. Global Market for L-Aspartic Acid by Geography
6.1 Overview
6.1.1 Market Size and Forecast
6.2 North America
6.2.1 Market Size and Forecast
6.2.2 North America: L-Aspartic Acid Market by Country
6.2.2.1 United States
6.2.2.2 Canada
6.2.2.3 Mexico
6.3 Europe
6.3.1 Market Size and Forecast
6.3.2 Europe: L-Aspartic Acid Market by Country
6.3.2.1 Germany
6.3.2.2 France
6.3.2.3 United Kingdom
6.3.2.4 Italy
6.3.2.5 Rest of The Europe
6.4 Asia-Pacific
6.4.1 Market Size and Forecast
6.4.2 Asia-Pacific: L-Aspartic Acid Market by Country
6.4.2.1 China
6.4.2.2 India
6.4.2.3 Japan
6.4.2.4 South Korea
6.4.2.5 ASEAN Countries
6.5 Middle East and Africa (MEA)
6.5.1 Market Size and Forecast
6.5.2 MEA: L-Aspartic Acid Market by Country
6.5.2.1 Saudi Arabia
6.5.2.2 South Africa
6.5.2.3 Turkey
6.6 South America
6.6.1 Market Size and Forecast
6.6.2 South America: L-Aspartic Acid Market by Country
6.6.2.1 Brazil
6.6.2.2 Argentina
6.6.2.3 Rest of South America

Part 7. Competitive Landscape
7.1 Market Share
7.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

Part 8. Key Competitor Profiles
8.1 Ajinomoto Co., Inc.
8.2 Changmao Biochemical Engineering Company Limited
8.3 Changzhou Yabang Chemical Co., Ltd.
8.4 Evonik Industries AG
8.5 Huaibei Xinxing Industrial Co., Ltd.
8.6 Jiangsu Jiecheng Bioengineering Co., Ltd.
8.7 Koninklijke DSM N.V.
8.8 Kyowa Hakko Bio Co., Ltd.
8.9 Tianjin Bohua Zhonghe Chemical Co., Ltd.
8.10 Yantai Hengyuan Bioengineering Co., Ltd.
*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY